The FDA has granted Fast Track designation to Erasca’s investigational [...]

Qureight has opened a second UK site in London as [...]

A survey of more than 50 senior pharmaceutical and biotechnology [...]

NICE has recommended glycopyrronium bromide cream as an option for [...]

AC Immune has received FDA Fast Track designation and IND [...]

Biotech company LifeMine Therapeutics has raised $263 million to support [...]

Adneuris Therapeutics has granted Maruishi Pharmaceutical exclusive rights to develop [...]

Vaximm AG has completed analysis of two clinical studies evaluating [...]

Medicus Pharma has received authorisation from the UAE Department of [...]

Qureight has raised $20 million in a Series B financing [...]